ASTRAPHARM
- · Thesis: well-run, low negotiation leverage
Opportunity 73/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (63/100).
Data confidence
Overall: medium (60/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 accounts
- • 1 accounts
- • 1 confirmation-statement
- • 1 accounts
- • 1 confirmation-statement
Corporate timeline (56 events)Click to expand
- 2026-05-19📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-05-02📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-05-01➕TATTERSALL, Hannah Victoria appointeddirector
- 2025-05-01➖KEMP, Adrian Charles Noel resigneddirector
- 2025-05-01📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-04-22📄accounts-with-accounts-type-dormantaccounts · AA
- 2024-11-23📄memorandum-articlesincorporation · MA
- 2024-11-23📄resolutionresolution · RESOLUTIONS
- 2024-11-20📄statement-of-companys-objectschange-of-constitution · CC04
- 2024-05-07📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-05-01📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-08-16📄change-person-director-company-with-change-dateofficers · CH01
- 2022-06-24📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-12-06📄change-person-director-company-with-change-dateofficers · CH01
- 2021-07-06📄accounts-with-accounts-type-dormantaccounts · AA
- 2020-11-11📄change-person-director-company-with-change-dateofficers · CH01
- 2020-09-03📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-08-09📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-08-01📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2019-08-01📄appoint-person-secretary-company-with-name-dateofficers · AP03
- 2019-07-31➕JOHNSTONE, Camilla Jane appointedsecretary
- 2019-07-31➖CONACHER, Matthew Ian resignedsecretary
- 2019-02-27➕BOWDEN, Matthew Shaun appointeddirector
- 2019-02-27➖JACKSON-TURNER, Katie Louise resigneddirector
- 2017-05-31➕COLLINS, Iain Alistair appointeddirector
- 2017-05-31➖BRIMICOMBE, Ian Martin David resigneddirector
- 2017-03-16➕CONACHER, Matthew Ian appointedsecretary
- 2017-03-16➕KEMP, Adrian Charles Noel appointeddirector
- 2016-09-21➖TALIADOROS, Kim Jehan resignedsecretary
- 2015-07-31➖O'GRADY, Claire-Marie resigneddirector
- 2015-07-15➕JACKSON-TURNER, Katie Louise appointeddirector
- 2012-01-10➖HOSKINS, Justin Wilbert resigneddirector
- 2012-01-10➕O'GRADY, Claire-Marie appointeddirector
- 2011-03-31➖LACHLAN, Cacilia Maria resignedsecretary
- 2011-03-31➕TALIADOROS, Kim Jehan appointedsecretary
- 2006-11-20➕HOSKINS, Justin Wilbert appointeddirector
- 2006-11-20➖KEMP, Adrian Charles Noel resigneddirector
- 2004-11-01➖GRADY, Shaun Francis resigneddirector
- 2003-10-10➕KEMP, Adrian Charles Noel appointeddirector
- 2000-11-10➖BACHE, David Colin resignedsecretary
- 2000-11-10➕LACHLAN, Cacilia Maria appointedsecretary
- 2000-11-09➖BANKS, Caroline Mary resigneddirector
- 2000-11-09➕BRIMICOMBE, Ian Martin David appointeddirector
- 2000-01-05➖KELLY, Linda Mary resigneddirector
- 2000-01-04➕BANKS, Caroline Mary appointeddirector
- 2000-01-04➕GRADY, Shaun Francis appointeddirector
- 1998-06-29➕BACHE, David Colin appointedsecretary
- 1998-05-14➖VIGART, Nicholas Peter resignedsecretary
- 1998-05-14➖VIGART, Nicholas Peter resigneddirector
- 1996-08-14➖KIRBY, Pamela Josephine, Dr resigneddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
Red flags
cleanGroup structure
Astrazeneca Treasury Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Astrazeneca Treasury Limited Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Holding company · CB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ARM TECHNOLOGY INVESTMENTS LIMITED→ 09195191 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ARTIN HOLDING LTD→ 16901376 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ASHCROFT YARD LIMITED→ 16831994 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ASPHALT GROUP LIMITED→ 11405056 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ASPIRE HOLDINGS (CAMBS) LTD→ 15808503 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED→ 04145522 · est 2001 · no financials extracted | — | — | — | — | 25y | — | — |
| ASTRAZENECA INVESTMENTS LIMITED→ 02728922 · est 1992 · no financials extracted | — | — | — | — | 33y | — | — |
| ASTRAZENECA JAPAN LIMITED→ 04020131 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
| ASTRAZENECA NOMINEES LIMITED→ 02728920 · est 1992 · no financials extracted | — | — | — | — | 33y | — | — |
| ASTRO BIDCO LIMITED→ 11514538 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AT NO.1 LIMITED→ 13397049 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ATHERTON CLOSE RESIDENTS LIMITED→ 04268766 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 18 resigned)
Click a director name to see their full track record across all companies.